The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of cabazitaxel ± rhenium-188-HEDP in patients with metastatic castration resistant prostate cancer who progressed on or after a docetaxel containing treatment.
 
Esther W. Bouman-Wammes
Research Funding - Sanofi (Inst)
 
Joyce M. van Dodewaard-de Jong
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis
 
Haiko Bloemendal
Research Funding - Sanofi (Inst)
 
John M. H. de Klerk
No Relationships to Disclose
 
Henk M.W. Verheul
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim (Inst)
Research Funding - Amgen (Inst); Immunovo (Inst); Roche (Inst); Vitromics (Inst)
 
Alfonsus Johannes Maria van den Eertwegh
Honoraria - Astellas Pharma; Bayer
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst)
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma